Novo Nordisk , whose global profile has risen along with demand for its Wegovy weight-loss drug, is bolstering operations in ...

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on ...

Zmyra is known as the top over-the-counter alternative to Wegovy for weight loss. This natural supplement packs a punch with ...

Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market ...

Allowing Medicare to cover popular weight loss drugs such as Wegovy and Zepbound could increase federal spending by billions ...

The embattled diet brand said it is adding a compounded weight-loss drug in accordance with FDA rules and manufacturing ...

Men, baby boomers, and postgraduate-degree holders were among those most likely to say they wouldn’t choose medication over ...

France has refused to endorse prescribing weight loss drug, Wegovy through its national insurance system, despite being on ...

Unlike Ozempic, Wegovy is approved for weight management even though they both contain semaglutide. However, they do have ...

Novo Nordisk (NVO) and Viatris (VTRS) have reportedly reached an agreement in their dispute over U.S. patents protecting Novo ...

U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...

A new trial reveals that weekly injections of the weight-loss drug Wegovy (semaglutide) lowered the risk of death from COVID-19 by about a third and reduced overall mortality by 19%.